John Wideman, MD
Obstetrics & Gynecology · Cullman, ALNPI 1336255728
Payments from drug & device makers
Across 227 payments — averaging $10,005 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2.3M
- AbbVie$455
- Shield Therapeutics Inc$245
- Aspira Women's Health Inc$216
- Amgen$125
- Myriad Women's Health, Inc.$117
- plus $977 from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 115 | $2,268,996 |
| AbbVie | 35 | $455 |
| Shield Therapeutics Inc | 12 | $245 |
| Aspira Women's Health Inc | 2 | $216 |
| Amgen | 10 | $125 |
| Myriad Women's Health, Inc. | 1 | $117 |
| Boston Scientific | 1 | $76 |
| Organon | 4 | $67 |
| AMAG Pharmaceuticals, Inc. | 4 | $60 |
| Hologic Sales And Service, LLC | 3 | $56 |
| Astellas Pharma US Inc | 3 | $55 |
| Scynexis, Inc. | 3 | $53 |
| Avanos Medical | 2 | $52 |
| Duchesnay USA Incorporated | 4 | $52 |
| Siemens Medical Solutions USA, Inc. | 1 | $51 |
| Exeltis, USA Inc. | 2 | $47 |
| Radius Health, Inc. | 2 | $39 |
| Convatec Inc. | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $36 |
| Bayer | 2 | $34 |
| BD | 2 | $32 |
| Evofem Biosciences, Inc. | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Dexcom, Inc. | 1 | $24 |
| Covidien LP | 1 | $19 |
| Axonics, Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Orexo US, Inc. | 1 | $13 |
| Lupin Inc. | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
| Ascend Therapeutics US, LLC | 1 | $12 |
How this compares
$2,271,130 in reported general payments places this provider in the 95th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Cullman
- Guy MiddletonDothan$5.6M
- Charles SharpBirmingham$2.8M
- Charles RogersMobile$1.8M
- Ronald OrsoBirmingham$1.6M
- Amy McCoyMobile$1.2M
- Theodore CatranisMobile$994K
- Theodore TsaltasBirmingham$853K
- Janeen ArbuckleBirmingham$601K
- Phillip MadoniaMobile$574K
- Richard BrownGulf Shores$429K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.